CHICAGO, Feb. 19 /PRNewswire-FirstCall/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced the following changes to its Management Team to further serve its global customer base:
- Bryan T. Durkin, who has served as Chief Operating Officer since 2007, will now assume oversight of the company's Products & Services Division in addition to his current responsibilities. In his new role as Chief Operating Officer and Managing Director, Products & Services, Durkin will lead both the operations and sales functions for CME Group to focus on increasing product line growth and meeting customer needs worldwide. Durkin has nearly 30 years of industry experience, including senior leadership positions at CME Group and The Chicago Board of Trade. Durkin will continue to report to CME Group President Phupinder Gill.
- Rick Redding, who previously led Products & Services, has assumed a new planning role related to CME Group's pending ownership stake in a new index services venture with Dow Jones. Redding has an extensive background in equity markets, having previously run the company's equity product line for 10 years and forged strong relationships with all of its index licensors. Together with Scot Warren, Managing Director, Equity Products and Index Services, Redding will assist with the joint venture formation and strategic planning process. Redding also will work with Durkin for a transition period to ensure continuity in the company's efforts to develop its core business, OTC products and global sales force. Redding will assume the new role of Managing Director, Products & Services Initiatives, and he will report to Durkin.
- Kendal Vroman has been named Managing Director, Commodity Products, OTC Services & Information Products. Vroman most recently served as Managing Director & Chief Corporate Development Officer and has worked in a number of senior leadership roles at CME Group since 2001. In this role, he will oversee the company's energy, agricultural and metals commodities businesses. Laurent Paulhac, Managing Director, OTC Products and Services will report to Vroman, as will the company's information products business. Vroman will report to Durkin. Barry Goldblatt, who previously held the role of Managing Director, Commodities, Energy & Metals has resigned to pursue other interests.
- Scot E. Warren has been promoted to a new role on the company's management team as Managing Director, Equity Index Products & Index Services with continued responsibility for the company's equity product line, as well as additional responsibility for the company's index services business. Warren previously served as Managing Director, Equity Products and joined CME Group in 2007. He will report to Durkin.
- James E. Parisi will assume expanded responsibilities for the company's corporate development and corporate strategy functions as Chief Financial Officer and Managing Director, Finance & Corporate Development. Parisi joined CME Group in 1988. He will continue to report to Donohue. In addition, Jill A. Harley will assume an expanded role as Managing Director, Corporate Finance Services while James V. Pieper will assume the role of Managing Director & Chief Accounting Officer previously held by Harley. Pieper will continue to report to Harley, and Harley will continue to report to Parisi.
- John W. Pietrowicz has been promoted to a new role on the company's management team as Managing Director, Business Development & Corporate Finance. Pietrowicz will have day-to-day oversight of and responsibility identifying, negotiating, financing and managing ongoing investments in new business opportunities. Pietrowicz joined CME Group in 2003 and previously served as Managing Director & Deputy Chief Financial Officer. He will continue to report to Parisi.
The company also announced that Sean Keating, Managing Director, New York Operations will be assuming an expanded role as Managing Director and Head of CME Group's New York office, responsible for daily administration of New York operations. He will continue to report to Julie Holzrichter, CME Group Managing Director, Global Operations.
As the world's leading and most diverse derivatives marketplace, CME Group (www.cmegroup.com) is where the world comes to manage risk. CME Group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. CME Group brings buyers and sellers together through its CME Globex electronic trading platform and its trading facilities in New York and Chicago. CME Group also operates CME Clearing, one of the largest central counterparty clearing services in the world, which provides clearing and settlement services for exchange-traded contracts, as well as for over-the-counter derivatives transactions through CME ClearPort. These products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk in both listed and over-the-counter derivatives markets.
The Globe logo, CME, Chicago Mercantile Exchange, CME Group, Globex, E-mini and CME ClearPort are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of the Board of Trade of the City of Chicago. NYMEX and New York Mercantile Exchange are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. All other trademarks are the property of their respective owners. Further information about CME Group (NASDAQ: CME) and its products can be found at www.cmegroup.com.
CME-G
SOURCE CME Group
Share this article